SGEN - Seagen Inc.
IEX Last Trade
194.64
0.990 0.509%
Share volume: 642,442
Last Updated: Tue 08 Aug 2023 09:59:53 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-4.32%
PREVIOUS CLOSE
CHG
CHG%
$193.65
0.99
0.51%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-04-28 | 2022-07-28 | 2022-10-27 | 2023-02-15 | 2023-04-27 | 2023-08-02 | 2023-11-01 | |
Total revenue | 426.460 M | 497.502 M | 510.300 M | 528.150 M | 519.719 M | 603.832 M | 648.650 M | |
Cost of revenue | 87.626 M | 106.100 M | 108.122 M | 108.210 M | 111.776 M | 180.753 M | 165.254 M | |
Gross profit | 338.834 M | 391.402 M | 402.178 M | 419.940 M | 407.943 M | 423.079 M | 483.396 M | |
15.51% | 2.75% | 4.42% | -2.86% | 3.71% | 14.26% | |||
Operating expenses | 471.884 M | 524.513 M | 594.983 M | 573.944 M | 592.456 M | 643.800 M | 714.734 M | |
Selling general and admin | 174.225 M | 220.259 M | 210.378 M | 216.101 M | 236.441 M | 243.932 M | 265.687 M | |
Research and development | 297.659 M | 304.254 M | 384.605 M | 357.843 M | 356.015 M | 399.868 M | 449.047 M | |
Total expenses | 559.510 M | 630.613 M | 703.105 M | 682.154 M | 704.232 M | 824.553 M | 879.988 M | |
12.71% | 11.50% | -2.98% | 3.24% | 17.09% | 6.72% | |||
Operating income | -133.050 M | -133.111 M | -192.805 M | -154.004 M | -184.513 M | -220.721 M | -231.338 M | |
Ebit | -133.050 M | -133.111 M | -192.805 M | -154.004 M | -184.513 M | -220.721 M | -231.338 M | |
Pretax income | -135.240 M | -134.720 M | -188.527 M | -143.828 M | -170.113 M | -208.637 M | -216.360 M | |
-0.38% | 39.94% | -23.71% | 18.28% | 22.65% | 3.70% | |||
Income tax | 1.254 M | 107.000 K | 2.289 M | 4.343 M | 4.624 M | 2.891 M | -571.000 K | |
Net income basic | -136.494 M | -134.827 M | -190.816 M | -148.171 M | -174.737 M | -211.528 M | -215.789 M | |
1.22% | -41.53% | 22.35% | -17.93% | -21.06% | -2.01% | |||
Net income | -136.494 M | -134.827 M | -190.816 M | -148.171 M | -174.737 M | -211.528 M | -215.789 M | |
1.22% | -41.53% | 22.35% | -17.93% | -21.06% | -2.01% |